Ionis Pharmaceuticals logo

Ionis Pharmaceuticals (IONS) Q1 2025 Earnings

IONS·Reported April 30, 2025·Before market open

Ionis Pharmaceuticals reported Q1 2025 revenue of $131.6M (+10.6% YoY), missed analyst consensus of $150.6M by $19.0M. Diluted EPS came in at $-0.75 (+23.5% YoY), beat the $-1.11 consensus by $0.36.

Revenue
$131.6Mmissed by $19.0M
Consensus: $150.6M
Diluted EPS
$-0.75beat by $0.36
Consensus: $-1.11
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0000874015-25-000123

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Ionis Pharmaceuticals's Q1 2025 earnings report.

Ionis Pharmaceuticals (IONS) reported Q1 2025 earnings on April 30, 2025 before market open.

Ionis Pharmaceuticals reported revenue of $131.6M and diluted EPS of $-0.75 for Q1 2025.

Revenue missed the consensus estimate of $150.6M by $19.0M. EPS beat the consensus estimate of $-1.11 by $0.36.

Compared to the same quarter a year prior, revenue grew 10.6% from $119.0M a year earlier and diluted EPS grew 23.5% from $-0.98.

You can read the 10-Q periodic report (0000874015-25-000123) directly on SEC EDGAR. The filing index links above go to sec.gov.